
               
               
               7 DRUG INTERACTIONS
               
                  No drug-drug interaction studies were conducted.
                  Degarelix is not a substrate for the human CYP450 system. Degarelix is not an inducer or inhibitor of the CYP450 system in vitro.  Therefore, clinically significant CYP450 pharmacokinetic drug-drug interactions are unlikely.
               
               
               
                  
                     
                        Clinically significant CYP450 pharmacokinetic drug-drug interactions are unlikely. (7)
                     
                  
               
            
         